Sexually Transmitted Disease Testing Market Size

Sexually Transmitted Disease Testing Market size was valued at USD 107.01 billion in 2024 and is anticipated to reach USD 224.48 billion by the end of 2037, expanding at around 5.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of sexually transmitted disease testing is assessed at USD 112.06 billion.

An increase in cases of sexually transmitted diseases (STDs) in the younger adult population, followed by unprotected sex and a lower level of awareness about safe sex in younger adults, are expected to increase the transmission of diseases. Hence, it is anticipated to boost the growth of the global market. As per the data reported, every 1 in 4 teens gets infected by STD every year around the globe.

The rise in sexual crimes against women has accelerated the transmission of sexually transmitted infections among women. Rape, sexual molestation, and assault against women are expected to increase sexually transmitted diseases, which are projected to bring lucrative growth opportunities. According to the United Nations, globally, 736 million women, at least once in their lifetime have experienced sexual intimate partner violence, non-partner violence, or both. Furthermore, a higher number of people working as sex workers, insurance covering the treatment of STDs, and increased cases of STDs are propelling the growth of the global STD Testing Market. Moreover, HIV remains a significant public health concern around the world. Therefore, the goal of testing is to identify individuals that are suffering from the STD, so that it cannot be transferred to a healthy person. In the United Kingdom, for instance, the National Chlamydia Screening Program (NCSP) was launched in March 2022. The project's primary objective is to decrease the threat of undiagnosed chlamydia infection.